J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM

Watchlist Manager
J B Chemicals and Pharmaceuticals Ltd Logo
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Watchlist
Price: 1 859.7 INR -1.7% Market Closed
Market Cap: 289.2B INR
Have any thoughts about
J B Chemicals and Pharmaceuticals Ltd?
Write Note

Gross Margin
J B Chemicals and Pharmaceuticals Ltd

66.3%
Current
64%
Average
48.4%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
66.3%
=
Gross Profit
24.6B
/
Revenue
37.1B

Gross Margin Across Competitors

Country IN
Market Cap 288.6B INR
Gross Margin
66%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 756.3B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 2.7T DKK
Gross Margin
85%
Country US
Market Cap 349.7B USD
Gross Margin
69%
Country US
Market Cap 251.6B USD
Gross Margin
77%
Country CH
Market Cap 199.5B CHF
Gross Margin
73%
Country UK
Market Cap 161.6B GBP
Gross Margin
82%
Country CH
Market Cap 171.3B CHF
Gross Margin
75%
Country US
Market Cap 151.4B USD
Gross Margin
71%
No Stocks Found

J B Chemicals and Pharmaceuticals Ltd
Glance View

Market Cap
288.6B INR
Industry
Pharmaceuticals

In the bustling marketplace of India's pharmaceutical industry, J B Chemicals and Pharmaceuticals Ltd. has carved its niche, a testament to its strategic vision and operational prowess. Founded in 1976 by Janak Mehta, the company has grown from its humble beginnings into a leading player in both the domestic and international arenas. Originally rooted in the ethos of quality and innovation, it established a firm foothold in the pharmaceutical sector through a diverse portfolio that includes formulations, active pharmaceutical ingredients (APIs), and contract manufacturing. As a vertically integrated company, J B Chemicals leverages its ability to control the manufacturing process from start to finish, ensuring strict quality measures and cost efficiencies, vital in tackling industry competition and regulatory challenges. The heart of J B Chemicals’ revenue model is its well-rounded product line that spans a range of therapeutic categories, including gastrointestinal, cardiovascular, and anticold segments. Blockbuster brands like Cilacar and Metrogyl have propelled the company to the top ranks within India, while its export division flourishes, contributing significantly to total earnings. With footprints in more than 30 countries, particularly in Russia and South Africa, the company taps into the growing demand for generic medicines worldwide. Moreover, by embracing innovation and investing in research and development, J B Chemicals continues to introduce new and improved medical solutions, positioning itself as a dynamic player in meeting global healthcare needs.

JBCHEPHARM Intrinsic Value
1 252.85 INR
Overvaluation 33%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
66.3%
=
Gross Profit
24.6B
/
Revenue
37.1B
What is the Gross Margin of J B Chemicals and Pharmaceuticals Ltd?

Based on J B Chemicals and Pharmaceuticals Ltd's most recent financial statements, the company has Gross Margin of 66.3%.